europäisches medienkunst festival european media art ... - EMAF
Calaméo - GOUT.CH 2020 DE
Long-term prognostic value of longitudinal measurements of blood neurofilament levels | Neurology Neuroimmunology & Neuroinflammation
Screening, enrolment, randomisation and follow-up of study patients.... | Download Scientific Diagram
ePoster Presentation SNS, 2019
Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - - European ...
Erinnerungen 1848-1914 ..
Gesamtkatalog_Winkler_Blätterkatalog
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
GOUT.CH 2021 DE - Calaméo
Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - -
PEOPLE - HERZOG & DE MEURON
SI_2011_04 by Schweizer Illustrierte - Issuu
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
European Journal of Neurology: Vol 29, No 3
HANSEstyle 4 | 2018
PDF - Litblogs.net
PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
PEOPLE - HERZOG & DE MEURON
Migros-Magazin-20-2021-d-OS by Migros-Genossenschafts-Bund - Issuu
AAP Volltextsuche
PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
PDF) Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
Bödeli Info April by WEBER VERLAG - Issuu
